EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Han-Xu Li, Jian-Hui Tian iD, Hua-Yu Li, Xin Wan, Yu Zou iD

Molecules · 2023

DOI: 10.3390/molecules28083355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Han-Xu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Process, Hubei Province Key Laboratory of Occupationl Hazard Identification and Control, School of Medicine, Wuhan Univer…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Nitric Oxide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province of China, College Students' innovative Entrepreneurial Training Plan Program of Hubei province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiplatelet aggregation agents have demonstrated clinical benefits in the treatment of ischemic stroke. In our study, a series of novel nitric oxide (NO)-donating ligustrazine derivatives were designed and synthesized as antiplatelet aggregation agents. They were evaluated for the inhibitory effect on 5′-diphosphate (ADP)-induced and arachidonic acid (AA)-induced platelet aggregation in vitro. The results showed that compound 15d displayed the best activity in both ADP-induced and AA-induced assays, and compound 14a also showed quite better activity than ligustrazine. The preliminary structure-activity relationships of these novel NO-donating ligustrazine derivatives were discussed. Moreover, these compounds were docked with the thromboxane A2 receptor to study the structure-activity relationships. These results suggested that the novel NO-donating ligustrazine derivatives 14a and 15d deserve further study as potent antiplatelet aggregation agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsNitric OxidePlatelet AggregationPyrazinesStructure-Activity RelationshipArachidonic Acid

Stichwörter der Autor:innen

antiplatelet aggregation agentsligustrazinenitric oxide donorsstructure-activity relationships

Substanzen

Platelet Aggregation InhibitorstetramethylpyrazineNitric OxidePyrazinesArachidonic Acid

Autor:innen und Institutionen

  • Institute of Pharmaceutical Process, Hubei Province Key Laboratory of Occupationl Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.

ORCID-Profile: Jian-Hui Tian, Yu Zou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province of China
  • College Students' innovative Entrepreneurial Training Plan Program of Hubei province
  • College Students’ innovative Entrepreneurial Training Plan Program of Hubei province

Zitieren

APA

Li, H. X., Tian, J. H., Li, H. Y., Wan, X., & Zou, Y. (2023). Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents. Molecules. https://doi.org/10.3390/molecules28083355

Vancouver

Li HX, Tian JH, Li HY, Wan X, Zou Y. Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents. Molecules. 2023. doi:10.3390/molecules28083355

BibTeX
@article{Li2023,
  author = {Li, Han-Xu and Tian, Jian-Hui and Li, Hua-Yu and Wan, Xin and Zou, Yu},
  title = {Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28083355}
}
Kostenlos starten →